Dennis Burton has been a Professor of
Immunology at The Scripps Research Institute in La Jolla, California since
1991. He read Chemistry at Oxford and did a PhD in Lund, Sweden in physical
biochemistry. Through the '80s, he worked on the molecular basis of human
antibody effector function in Sheffield. In 1989, Burton joined a team at
Scripps to produce the first recombinant antibodies from phage libraries.
Since then he has focused on the interplay between human antibodies and pathogens,
particularly HIV, but also other viruses and prions. Most of his current
effort relates to the development of an HIV vaccine and the establishment
of rational molecular approaches to vaccine design in general.
